Cochrane · systematic review · CD011785

Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants

Green, DS, Abdel‐Latif, ME, Jones, LJ, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

NeonatalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 33.3%Low 3 · 50%Moderate 1 · 16.7%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Prevention of upper gastrointestinal bleeding in newborn infants

Population: newborn infants at risk of gastrointestinal bleeding
2 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality
RR 2.42 [0.7, 8.38]1 study · 53 participantsVery low
Downgraded: imprecision
Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding
RR 0.36 [0.22, 0.58]4 studies · 329 participantsModerate

Treatment of upper gastrointestinal bleeding in newborn infants

Population: infants with upper gastrointestinal bleeding
4 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality
RR 0.63 [0.26, 1.51]2 studies · 131 participantsLow
Downgraded: imprecision
Duration of upper gastrointestinal bleeding (days)
no estimate extracted2 studies · 104 participantsVery low
Downgraded: imprecision, inconsistency
Continued upper gastrointestinal bleeding
RR 0.36 [0.26, 0.49]6 studies · 451 participantsLow
Downgraded: inconsistency
Anaemia requiring blood transfusion
RR 0.6 [0.11, 3.19]1 study · 38 participantsLow
Downgraded: inconsistency